Advertisement

Index by author

November 01, 1981; Volume 219,Issue 2

A

  1. Abuchowski, A

    1. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
      A Abuchowski, D Karp and F F Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 352-354;

  2. Aiken, J W

    1. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
      J W Aiken, R J Shebuski, O V Miller and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 299-308;

  3. Alkadhi, K A

    1. Cyclic guanosine 3':5'-monophosphate accumulation and 45Ca-uptake by rat superior cervical ganglia during preganglionic stimulation.
      R L Volle, L F Quenzer, B A Patterson, K A Alkadhi and E G Henderson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 338-343;

  4. Angus, J A

    1. The histamine-like effects of tolazoline and clonidine:: evidence against direct activity at histamine receptors.
      T P Kenakin and J A Angus
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 474-480;

B

  1. Barker, L A

    1. Histamine H2-receptor antagonism by propantheline and derivatives.
      L B Hough and L A Barker
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 453-458;

  2. Benos, D J

    1. Inferences on the nature of the apical sodium entry site in frog skin epithelium.
      D J Benos and J W Watthey
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 481-488;

  3. Besseghir, K

    1. Renal tubule transport and electrolyte effects of amiloride in the chicken.
      K Besseghir and B Rennick
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 435-441;

  4. Brady, L S

    1. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
      L S Brady and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 344-351;

  5. Brunello, N

    1. The septal-hippocampal cholinergic pathway: role in antagonism of pentobarbital anesthesia and regulation by various afferents.
      N Brunello and D L Cheney
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 489-495;

C

  1. Cavero, I

    1. Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow.
      I Cavero, F Lefèvre-Borg and R Gomeni
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 510-519;

  2. Chang, J K

    1. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
      F C Tulunay, M F Jen, J K Chang, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 296-298;

  3. Cheney, D L

    1. The septal-hippocampal cholinergic pathway: role in antagonism of pentobarbital anesthesia and regulation by various afferents.
      N Brunello and D L Cheney
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 489-495;

  4. Chu, B C

    1. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
      B C Chu and S B Howell
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 389-393;

  5. Colasanti, B K

    1. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
      C Lindamood and B K Colasanti
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 580-584;

  6. Czervionke, R L

    1. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis.
      W M Parks, J C Hoak and R L Czervionke
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 415-419;

D

  1. Danis, M

    1. Role of reducing equivalents from fatty acid oxidation in mixed-function oxidation: studies with 2-bromooctanoate in the perfused rat liver.
      M Danis, F C Kauffman, R K Evans and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 383-388;

  2. Davis, B B

    1. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
      N S Rapp, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 442-446;

  3. Davis, F F

    1. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
      A Abuchowski, D Karp and F F Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 352-354;

  4. de Miranda, P

    1. The disposition of acyclovir in different species.
      P de Miranda, H C Krasny, D A Page and G B Elion
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 309-315;

  5. Drack, E

    1. Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon.
      U Scheurer, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 534-539;

  6. Dubois, A

    1. Effect of a prostaglandin F2 alpha analog on gastric emptying and secretion in rhesus monkeys.
      P T Shea-Donohue, D Nompleggi and A Dubois
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 287-289;

  7. Duval, N

    1. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
      N B Shepperson, N Duval, R Massingham and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 540-546;

E

  1. Elion, G B

    1. The disposition of acyclovir in different species.
      P de Miranda, H C Krasny, D A Page and G B Elion
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 309-315;

  2. Erlinger, S

    1. Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats.
      M Le Dafniet, D Pessayre, L Le Quernec and S Erlinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 558-562;

  3. Evans, R K

    1. Role of reducing equivalents from fatty acid oxidation in mixed-function oxidation: studies with 2-bromooctanoate in the perfused rat liver.
      M Danis, F C Kauffman, R K Evans and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 383-388;

F

  1. Fischer, L J

    1. Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose.
      L J Fischer, M D Green and A W Harman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 281-286;

G

  1. Gerber, J G

    1. Alpha adrenergic-mediated renin release is prostaglandin-dependent.
      R D Olson, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 321-325;

  2. Goblet, C

    1. Effects of ryanodine on the ionic currents and the calcium conductance in crab muscle fibers.
      C Goblet and Y Mounier
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 526-533;

  3. Goldman, S

    1. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
      S Goldman, M Olajos, H Pieniaszek, D Perrier, M Mayersohn and E Morkin
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 394-399;

  4. Gomeni, R

    1. Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow.
      I Cavero, F Lefèvre-Borg and R Gomeni
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 510-519;

  5. Gorman, R R

    1. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
      J W Aiken, R J Shebuski, O V Miller and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 299-308;

  6. Graham, R M

    1. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
      J M Schmitz, R M Graham, A Sagalowsky and W A Pettinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 400-406;

  7. Green, M D

    1. Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose.
      L J Fischer, M D Green and A W Harman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 281-286;

  8. Greenberg, S

    1. Effect of prostacyclin and 9a, 11a-epoxymethanoprostaglandin H2 on calcium and magnesium fluxes and tension development in canine intralobar pulmonary arteries and veins.
      S Greenberg
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 326-337;

H

  1. Haigler, H J

    1. Cyclic AMP, morphine, met-enkephalin and neuronal firing.
      D A Hosford and H J Haigler
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 496-504;

  2. Halter, F

    1. Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon.
      U Scheurer, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 534-539;

  3. Harman, A W

    1. Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose.
      L J Fischer, M D Green and A W Harman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 281-286;

  4. Hartmann, A

    1. Ethacrynic acid inhibits transcellular NaCl reabsorption in dog kidneys in doses of 1 to 10 mg.kg-1 and proximal bicarbonate-dependent reabsorption at higher doses.
      P A Steen, A Hartmann and F Kiil
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 505-509;

  5. Henderson, E G

    1. Cyclic guanosine 3':5'-monophosphate accumulation and 45Ca-uptake by rat superior cervical ganglia during preganglionic stimulation.
      R L Volle, L F Quenzer, B A Patterson, K A Alkadhi and E G Henderson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 338-343;

  6. Henry, S

    1. Fluoride inhibition of the hydro-osmotic response of the toad urinary bladder to antidiuretic hormone.
      T Yorio, R Sinclair and S Henry
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 459-463;

  7. Herz, A

    1. Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.
      R Schulz, M Wüster, P Rubini and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 547-550;

  8. Hoak, J C

    1. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis.
      W M Parks, J C Hoak and R L Czervionke
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 415-419;

  9. Hoffman, B B

    1. Alpha adrenergic receptor subtypes in rabbit uterus: mediation of myometrial contraction and regulation by estrogens.
      B B Hoffman, T N Lavin, R J Lefkowitz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 290-295;

  10. Holtzman, S G

    1. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
      L S Brady and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 344-351;

  11. Hosford, D A

    1. Cyclic AMP, morphine, met-enkephalin and neuronal firing.
      D A Hosford and H J Haigler
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 496-504;

  12. Hough, L B

    1. Histamine H2-receptor antagonism by propantheline and derivatives.
      L B Hough and L A Barker
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 453-458;

  13. Howell, S B

    1. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
      B C Chu and S B Howell
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 389-393;

I

  1. Ito, K

    1. Long-term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats.
      K Ito, H Koike, M Miyamoto, H Ozaki, T Kishimoto and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 520-525;

J

  1. Jen, M F

    1. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
      F C Tulunay, M F Jen, J K Chang, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 296-298;

  2. Johanson, C E

    1. A comparison of the behavioral effects of l- and dl-cathinone and d-amphetamine.
      C E Johanson and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 355-362;

  3. Johnson, M R

    1. Nantradol hydrochloride: pharmacokinetics and behavioral effects after acute and chronic treatment.
      H M McIlhenny, R W Mast, M R Johnson and G M Milne
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 363-369;

  4. Jones, D J

    1. Adenosine regulation of cyclic 3',5'-adenosine monophosphate formation in rat spinal cord.
      D J Jones
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 370-376;

K

  1. Karp, D

    1. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
      A Abuchowski, D Karp and F F Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 352-354;

  2. Kauffman, F C

    1. Role of reducing equivalents from fatty acid oxidation in mixed-function oxidation: studies with 2-bromooctanoate in the perfused rat liver.
      M Danis, F C Kauffman, R K Evans and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 383-388;

  3. Kenakin, T P

    1. The histamine-like effects of tolazoline and clonidine:: evidence against direct activity at histamine receptors.
      T P Kenakin and J A Angus
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 474-480;

  4. Kiil, F

    1. Ethacrynic acid inhibits transcellular NaCl reabsorption in dog kidneys in doses of 1 to 10 mg.kg-1 and proximal bicarbonate-dependent reabsorption at higher doses.
      P A Steen, A Hartmann and F Kiil
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 505-509;

  5. Kishimoto, T

    1. Long-term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats.
      K Ito, H Koike, M Miyamoto, H Ozaki, T Kishimoto and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 520-525;

  6. Knight, R G

    1. Effects of rubidium on contractility and sodium pump activity in guinea-pig ventricle.
      R G Knight and T M Nosek
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 573-579;

  7. Koike, H

    1. Long-term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats.
      K Ito, H Koike, M Miyamoto, H Ozaki, T Kishimoto and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 520-525;

  8. Kong, S K

    1. Pharmacological studies of sensitized canine pulmonary blood vessels.
      S K Kong and N L Stephens
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 551-557;

  9. Koup, J R

    1. Chloramphenicol succinate pharmacokinetics in Macaca nemestrina: dose dependency study.
      J R Koup, A Weber and A L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 316-320;

  10. Krasny, H C

    1. The disposition of acyclovir in different species.
      P de Miranda, H C Krasny, D A Page and G B Elion
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 309-315;

L

  1. Langer, S Z

    1. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
      N B Shepperson, N Duval, R Massingham and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 540-546;

  2. Lau, S S

    1. Bromobenzene epoxidation leading to binding on macromolecular protein sites.
      S S Lau and V G Zannoni
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 563-572;

  3. Lavin, T N

    1. Alpha adrenergic receptor subtypes in rabbit uterus: mediation of myometrial contraction and regulation by estrogens.
      B B Hoffman, T N Lavin, R J Lefkowitz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 290-295;

  4. Le Dafniet, M

    1. Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats.
      M Le Dafniet, D Pessayre, L Le Quernec and S Erlinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 558-562;

  5. Lee, N M

    1. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
      F C Tulunay, M F Jen, J K Chang, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 296-298;

  6. Lefèvre-Borg, F

    1. Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow.
      I Cavero, F Lefèvre-Borg and R Gomeni
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 510-519;

  7. Lefkowitz, R J

    1. Alpha adrenergic receptor subtypes in rabbit uterus: mediation of myometrial contraction and regulation by estrogens.
      B B Hoffman, T N Lavin, R J Lefkowitz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 290-295;

  8. Le Quernec, L

    1. Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats.
      M Le Dafniet, D Pessayre, L Le Quernec and S Erlinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 558-562;

  9. Lindamood, C

    1. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
      C Lindamood and B K Colasanti
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 580-584;

  10. Loh, H H

    1. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
      F C Tulunay, M F Jen, J K Chang, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 296-298;

  11. Lund, A E

    1. Kinetics of sodium channel modification by the insecticide tetramethrin in squid axon membranes.
      A E Lund and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 464-473;

M

  1. Malik, K U

    1. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
      H Susić and K U Malik
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 377-382;

  2. Massingham, R

    1. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
      N B Shepperson, N Duval, R Massingham and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 540-546;

  3. Mast, R W

    1. Nantradol hydrochloride: pharmacokinetics and behavioral effects after acute and chronic treatment.
      H M McIlhenny, R W Mast, M R Johnson and G M Milne
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 363-369;

  4. Mattammal, M B

    1. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
      N S Rapp, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 442-446;

  5. Mayersohn, M

    1. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
      S Goldman, M Olajos, H Pieniaszek, D Perrier, M Mayersohn and E Morkin
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 394-399;

  6. McIlhenny, H M

    1. Nantradol hydrochloride: pharmacokinetics and behavioral effects after acute and chronic treatment.
      H M McIlhenny, R W Mast, M R Johnson and G M Milne
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 363-369;

  7. Miller, D S

    1. Heavy metal inhibition of p-aminohippurate transport in flounder renal tissue: sites of HgCl2 action.
      D S Miller
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 428-434;

  8. Miller, O V

    1. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
      J W Aiken, R J Shebuski, O V Miller and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 299-308;

  9. Milne, G M

    1. Nantradol hydrochloride: pharmacokinetics and behavioral effects after acute and chronic treatment.
      H M McIlhenny, R W Mast, M R Johnson and G M Milne
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 363-369;

  10. Miyamoto, M

    1. Long-term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats.
      K Ito, H Koike, M Miyamoto, H Ozaki, T Kishimoto and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 520-525;

  11. Morkin, E

    1. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
      S Goldman, M Olajos, H Pieniaszek, D Perrier, M Mayersohn and E Morkin
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 394-399;

  12. Mounier, Y

    1. Effects of ryanodine on the ionic currents and the calcium conductance in crab muscle fibers.
      C Goblet and Y Mounier
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 526-533;

  13. Murphy, P J

    1. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
      R R Ruffolo, T A Spradlin, G D Pollock, J E Waddell and P J Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 447-452;

N

  1. Narahashi, T

    1. Kinetics of sodium channel modification by the insecticide tetramethrin in squid axon membranes.
      A E Lund and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 464-473;

  2. Nies, A S

    1. Alpha adrenergic-mediated renin release is prostaglandin-dependent.
      R D Olson, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 321-325;

  3. Nompleggi, D

    1. Effect of a prostaglandin F2 alpha analog on gastric emptying and secretion in rhesus monkeys.
      P T Shea-Donohue, D Nompleggi and A Dubois
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 287-289;

  4. Nosek, T M

    1. Effects of rubidium on contractility and sodium pump activity in guinea-pig ventricle.
      R G Knight and T M Nosek
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 573-579;

O

  1. Olajos, M

    1. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
      S Goldman, M Olajos, H Pieniaszek, D Perrier, M Mayersohn and E Morkin
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 394-399;

  2. Olson, R D

    1. Alpha adrenergic-mediated renin release is prostaglandin-dependent.
      R D Olson, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 321-325;

  3. Ozaki, H

    1. Long-term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats.
      K Ito, H Koike, M Miyamoto, H Ozaki, T Kishimoto and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 520-525;

P

  1. Page, D A

    1. The disposition of acyclovir in different species.
      P de Miranda, H C Krasny, D A Page and G B Elion
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 309-315;

  2. Parks, W M

    1. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis.
      W M Parks, J C Hoak and R L Czervionke
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 415-419;

  3. Patterson, B A

    1. Cyclic guanosine 3':5'-monophosphate accumulation and 45Ca-uptake by rat superior cervical ganglia during preganglionic stimulation.
      R L Volle, L F Quenzer, B A Patterson, K A Alkadhi and E G Henderson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 338-343;

  4. Perrier, D

    1. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
      S Goldman, M Olajos, H Pieniaszek, D Perrier, M Mayersohn and E Morkin
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 394-399;

  5. Pessayre, D

    1. Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats.
      M Le Dafniet, D Pessayre, L Le Quernec and S Erlinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 558-562;

  6. Pettinger, W A

    1. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
      J M Schmitz, R M Graham, A Sagalowsky and W A Pettinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 400-406;

  7. Pieniaszek, H

    1. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
      S Goldman, M Olajos, H Pieniaszek, D Perrier, M Mayersohn and E Morkin
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 394-399;

  8. Pollock, G D

    1. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
      R R Ruffolo, T A Spradlin, G D Pollock, J E Waddell and P J Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 447-452;

Q

  1. Quenzer, L F

    1. Cyclic guanosine 3':5'-monophosphate accumulation and 45Ca-uptake by rat superior cervical ganglia during preganglionic stimulation.
      R L Volle, L F Quenzer, B A Patterson, K A Alkadhi and E G Henderson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 338-343;

R

  1. Rapp, N S

    1. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
      N S Rapp, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 442-446;

  2. Rennick, B

    1. Renal tubule transport and electrolyte effects of amiloride in the chicken.
      K Besseghir and B Rennick
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 435-441;

  3. Rubini, P

    1. Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.
      R Schulz, M Wüster, P Rubini and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 547-550;

  4. Ruffolo, R R

    1. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
      R R Ruffolo, T A Spradlin, G D Pollock, J E Waddell and P J Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 447-452;
    2. Alpha adrenergic receptor subtypes in rabbit uterus: mediation of myometrial contraction and regulation by estrogens.
      B B Hoffman, T N Lavin, R J Lefkowitz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 290-295;

S

  1. Sagalowsky, A

    1. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
      J M Schmitz, R M Graham, A Sagalowsky and W A Pettinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 400-406;

  2. Scheurer, U

    1. Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon.
      U Scheurer, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 534-539;

  3. Schmidt, R

    1. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
      S L Schmitt, K Taylor, R Schmidt, D Van Orden and H E Williamson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 407-414;

  4. Schmitt, S L

    1. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
      S L Schmitt, K Taylor, R Schmidt, D Van Orden and H E Williamson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 407-414;

  5. Schmitz, J M

    1. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
      J M Schmitz, R M Graham, A Sagalowsky and W A Pettinger
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 400-406;

  6. Schulz, R

    1. Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.
      R Schulz, M Wüster, P Rubini and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 547-550;

  7. Schuster, C R

    1. A comparison of the behavioral effects of l- and dl-cathinone and d-amphetamine.
      C E Johanson and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 355-362;

  8. Shea-Donohue, P T

    1. Effect of a prostaglandin F2 alpha analog on gastric emptying and secretion in rhesus monkeys.
      P T Shea-Donohue, D Nompleggi and A Dubois
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 287-289;

  9. Shebuski, R J

    1. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
      J W Aiken, R J Shebuski, O V Miller and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 299-308;

  10. Shepperson, N B

    1. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
      N B Shepperson, N Duval, R Massingham and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 540-546;

  11. Sinclair, R

    1. Fluoride inhibition of the hydro-osmotic response of the toad urinary bladder to antidiuretic hormone.
      T Yorio, R Sinclair and S Henry
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 459-463;

  12. Smith, A L

    1. Chloramphenicol succinate pharmacokinetics in Macaca nemestrina: dose dependency study.
      J R Koup, A Weber and A L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 316-320;

  13. Spradlin, T A

    1. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
      R R Ruffolo, T A Spradlin, G D Pollock, J E Waddell and P J Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 447-452;

  14. Steen, P A

    1. Ethacrynic acid inhibits transcellular NaCl reabsorption in dog kidneys in doses of 1 to 10 mg.kg-1 and proximal bicarbonate-dependent reabsorption at higher doses.
      P A Steen, A Hartmann and F Kiil
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 505-509;

  15. Stephens, N L

    1. Pharmacological studies of sensitized canine pulmonary blood vessels.
      S K Kong and N L Stephens
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 551-557;

  16. Susić, H

    1. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
      H Susić and K U Malik
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 377-382;

T

  1. Takimoto, G S

    1. Effects of nitroprusside-induced hypotension on sympathetic nerve activity, tyrosine hydroxylase activity and [3H]norepinephrine uptake in rabbit vascular tissues.
      G S Takimoto and N Weiner
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 420-427;

  2. Taylor, K

    1. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
      S L Schmitt, K Taylor, R Schmidt, D Van Orden and H E Williamson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 407-414;

  3. Thurman, R G

    1. Role of reducing equivalents from fatty acid oxidation in mixed-function oxidation: studies with 2-bromooctanoate in the perfused rat liver.
      M Danis, F C Kauffman, R K Evans and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 383-388;

  4. Tulunay, F C

    1. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
      F C Tulunay, M F Jen, J K Chang, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 296-298;

U

  1. Urakawa, N

    1. Long-term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats.
      K Ito, H Koike, M Miyamoto, H Ozaki, T Kishimoto and N Urakawa
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 520-525;

V

  1. Van Orden, D

    1. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
      S L Schmitt, K Taylor, R Schmidt, D Van Orden and H E Williamson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 407-414;

  2. Varga, L

    1. Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon.
      U Scheurer, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 534-539;

  3. Volle, R L

    1. Cyclic guanosine 3':5'-monophosphate accumulation and 45Ca-uptake by rat superior cervical ganglia during preganglionic stimulation.
      R L Volle, L F Quenzer, B A Patterson, K A Alkadhi and E G Henderson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 338-343;

W

  1. Waddell, J E

    1. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
      R R Ruffolo, T A Spradlin, G D Pollock, J E Waddell and P J Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 447-452;

  2. Watthey, J W

    1. Inferences on the nature of the apical sodium entry site in frog skin epithelium.
      D J Benos and J W Watthey
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 481-488;

  3. Weber, A

    1. Chloramphenicol succinate pharmacokinetics in Macaca nemestrina: dose dependency study.
      J R Koup, A Weber and A L Smith
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 316-320;

  4. Weiner, N

    1. Effects of nitroprusside-induced hypotension on sympathetic nerve activity, tyrosine hydroxylase activity and [3H]norepinephrine uptake in rabbit vascular tissues.
      G S Takimoto and N Weiner
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 420-427;

  5. Williamson, H E

    1. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
      S L Schmitt, K Taylor, R Schmidt, D Van Orden and H E Williamson
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 407-414;

  6. Wüster, M

    1. Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.
      R Schulz, M Wüster, P Rubini and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 547-550;

Y

  1. Yorio, T

    1. Fluoride inhibition of the hydro-osmotic response of the toad urinary bladder to antidiuretic hormone.
      T Yorio, R Sinclair and S Henry
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 459-463;

Z

  1. Zannoni, V G

    1. Bromobenzene epoxidation leading to binding on macromolecular protein sites.
      S S Lau and V G Zannoni
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 563-572;

  2. Zenser, T V

    1. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
      N S Rapp, T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics November 1981, 219 (2) 442-446;
Back to top

In this issue

Advertisement